Journal Logo

February 2018 - Volume 28 - Issue 1
pp: 1-78

Basic science

In vitro and in vivo antimelanoma effect of ethyl ester cyclohexyl analog of ethylenediamine dipropanoic acid

Isakovic, Andjelka M.; Petricevic, Sasa M.; Ristic, Slavica M.; More

Melanoma Research. 28(1):8-20, February 2018.

Translational research

Clinical research

Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB–IVM1c melanoma

Chesney, Jason; Awasthi, Sanjay; Curti, Brendan; More

Melanoma Research. 28(1):44-51, February 2018.

Analysis of survival of patients treated with vemurafenib, ipilimumab and dabrafenib for advanced skin melanoma in daily clinical practice (Real-World Data): retrospective analysis of patients treated under drug/reimbursement programmes in Poland in 2013–2016

Brzozowska, Melania; Wierzba, Waldemar; Sliwczynski, Andrzej; More

Melanoma Research. 28(1):52-55, February 2018.

Epidemiology of melanoma

Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy

Seremet, Teofila; Planken, Simon; Schreuer, Max; More

Melanoma Research. 28(1):65-70, February 2018.